Health Boards
›
Psoriasis In The News
Zasocitinib outperforms Deucravacitinib in phase 3 psoriasis study
|
Zasocitinib outperforms Deucravacitinib in phase 3 psoriasis study
|
Sat-13-06-2026, 19:24 PM
I always wonder why they do only a sole study for psoriasis, while it could be easily combined with Psoriatic Arthritis in the studies.
Now they have to do everything again for Psoriatic Arthritis. And if pharma is doing a study, that is always costing an amazing lot of money. |
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
Zasocitinib outperforms Deucravacitinib in phase 3 psoriasis study - by Fred - Sat-13-06-2026, 11:53 AM
RE: Zasocitinib outperforms Deucravacitinib in phase 3 psoriasis study - by Caroline - Sat-13-06-2026, 19:24 PM
RE: Zasocitinib outperforms Deucravacitinib in phase 3 psoriasis study - by Fred - Sat-13-06-2026, 20:44 PM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
| Socrodeucitinib for psoriasis phase 2 trial | Fred | 2 | 1,405 |
Fri-31-07-2026, 10:33 AM Last Post: Waine |
|
| Zasocitinib for psoriasis new data | Fred | 0 | 1,287 |
Fri-24-07-2026, 11:42 AM Last Post: Fred |
|
| ORKA-001 for psoriasis phase 2a | Fred | 1 | 3,181 |
Mon-27-04-2026, 12:45 PM Last Post: Fred |
|
| Envudeucitinib for psoriasis phase 3 results | Fred | 0 | 1,429 |
Sun-29-03-2026, 11:03 AM Last Post: Fred |
|
| Phase 1 study of Balinatunfib for psoriasis | Fred | 0 | 1,472 |
Fri-13-02-2026, 13:40 PM Last Post: Fred |
|
